Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Thalidomide 4etheralkylC8acid
is the potent and selective small molecular inhibitor of KRAS-PDEδ interaction
The CBL0137 hydrochloride monotherapy group and the CBL0137 hydrochloride-gemcitabine combination group samples show large necrotic fields
WSB1 Degrader 1 can only block the wound-healing capability of wild-type A2780 (A2780-WT) cells but not the A2780-WSB1/KO cells
gene expression is largely unaffected by PT2399 in resistant tumors
Ac-IEPD-AFC 11β-Hydroxyatis-16-ene-3 14-dione Thalidomide 4etheralkylC8acidAc IEPD AFC is a substrate of Granzyme B. Product information CAS Number: 1135417 31 0 Molecular Weight: 725. 67 Formula: C32H38F3N5O11 Chemical Name: 5 {2 [(2 carboxy 1 {[2 oxo 4 (trifluoromethyl) 2H chromen 7 yl]carbamoyl}ethyl)carbamoyl]pyrrolidin 1 yl} 4 (2 acetamido 3 methylpentanamido) 5 oxopentanoic acid Smiles: CC(=O)NC(C(C)CC)C(=O)NC(CCC(O)=O)C(=O)N1CCCC1C(=O)NC(CC(O)=O)C(=O)NC1=CC2OC(=O)C=C(C=2C=C1)C(F)(F)F InChiKey: HWXKKVLJPWMVLL